The Winning Formula
for Champions
There are no known contraindications to the use of intramuscular Adequan
®
i.m. brand Polysulfated Glycosaminoglycan in horses. Studies have not
been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans.
Keep this and all medications out of the reach of children. Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Each 5 mL contains 500 mg Polysulfated Glycosaminoglycan. Brief Summary Indications: For the intramuscular treatment of non-infectious degenera-
tive and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.
SEE PRODUCT PACKAGE INSERTS AT WWW.ADEQUAN.COM FOR FULL PRESCRIBING INFORMATION
Adequan
®
is a registered trademark of Luitpold Pharmaceuticals, Inc. ©LUITPOLD PHARMACEUTICALS, INC., Animal Health Division, 2014
Shirley, NY 11967. Image of Georgina Bloomberg ©Molly Sorge/The Chronicle of the Horse used with permission. AHD073, Iss. 10/2014
Georgina Bloomberg and Juvina won the Central Park
Grand Prix at the 2014 Central Park Horse Show Presented
by Rolex in New York City
Adequan
®
i.m. (polysulfated glycosaminoglycan) is the only product approved by the FDA for the intramuscular treatment of non-infectious degenerative
and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. To learn more, visit www.adequan.com.
Adequan
®
i.m. is now available through your veterinarian.